250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical Device VC (Venture Capital) Funds in Ireland in May 2025

A list of 50 VC (Venture Capital) funds that invest in Medical device startups based in Ireland. We rank investors based on the number of investments they made in Medical device companies from Ireland. We update this investor list every month.

Top 50 Medical Device VC (Venture Capital) Funds in Ireland in May 2025

Investor Medical Device Ireland investments
Enterprise Ireland 35
Western Development Commission 16
Atlantic Bridge University Fund 12
HBAN 12
Irrus Investments 11
SOSV 10
HBAN Medtech Syndicate 8
Atlantic Bridge 8
Furthr VC 8
Elkstone Capital Partners 8
Enterprise Equity 7
EIT Health 6
Fountain Healthcare Partners 6
EQT Life Sciences 5
Act Venture Capital 5
Business Venture Partners 4
AIB Seed Capital Fund 4
Ascentifi 4
Boole 4
Xenium Capital 4
Delta Partners 4
NDRC 3
Medtech Syndicate Nominee 3
Lightstone Ventures 3
Seroba Life Sciences 3
Boole Investment Syndicate 3
Broadview Ventures 3
Kernel Capital 2
Gilde Healthcare 2
Oyster Capital Partners 2
Mayo Clinic Ventures 2
imec.xpand 2
Life Sciences Fund Amsterdam 2
Cantor Fitzgerald 2
Faber 2
CAJU Venture Partners 2
European Investment Bank 2
Partisan Management Group 2
Glanzmann Enterprises 2
Pareto Holdings 1
The University of Vermont Health Network 1
HBM-MedFocus 1
Quorndon Capital 1
Lachy Groom 1
Norgine Ventures 1
COSIMO Ventures 1
GM&C Life Sciences Fund 1
Bioverge 1
Sure Valley Ventures 1
Kidron 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Enterprise Ireland VC Fund · Dublin, Dublin, Ireland · 32 investments in the past 12 months
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Funding Round, Series A
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Axe — Axe is a software firm that develops procurement software for businesses.
  • Assiduous — The AI-enabled platform to do the heavy-lifting for business owners seeking finance for their aspiring growth company.
  • Galway Biomedical — Galway Biomedical develops and manufactures medical devices.
Western Development Commission VC Fund · Ballaghaderreen, Roscommon, Ireland · 3 investments in the past 12 months
Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Seed, Funding Round, Series A
  • Ireland, United States
Portfolio highlights
  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • Peroptyx — Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts.
  • Galway Biomedical — Galway Biomedical develops and manufactures medical devices.
Atlantic Bridge University Fund VC Fund · Dublin, Dublin, Ireland
Atlantic Bridge University Fund invest in entrepreneurs with the ambition to create world-class companies of scale. A €60m investment fund to accelerate the commercialisation of ground-breaking research and the scaling of global businesses.
Show more
Investment focus
  • Medical Device, Health Care, Big Data
  • Seed, Series A, Funding Round
  • Ireland, United States
Portfolio highlights
  • CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
  • ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
  • Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland
HBAN VC Fund · Dublin, Dublin, Ireland · 3 investments in the past 12 months
HBAN is dedicated to raising the profile of business angel investment as an asset class on the island of Ireland and to promote the creation of business angel syndicates.
Show more
Investment focus
  • Health Care, Medical Device, Software
  • Seed, Funding Round, Series A
  • Ireland, United Kingdom, United States
Portfolio highlights
  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • Educatly — We help you get into the University of your dreams. We are the only platform with all the information you need to Study Abroad
  • Change by Degrees — Change by degrees supports individuals and organizations in developing sustainable competencies and gaining self-assurance to achieve sustainability goals, expand their businesses, and adhere to legal requirements.
Irrus Investments VC Fund · Limerick, Limerick, Ireland · 2 investments in the past 12 months
Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.
Show more
Investment focus
  • Medical Device, Biotechnology, Health Care
  • Seed, Funding Round, Series A
  • Ireland, Sweden, United States
Portfolio highlights
  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
  • SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
SOSV VC Fund · Princeton, New Jersey, United States · 75 investments in the past 12 months
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Convertible Note, Pre-Seed
  • United States, India, United Kingdom
Portfolio highlights
  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
HBAN Medtech Syndicate VC Fund
HBAN Medtech Syndicate
Show more
Investment focus
  • Medical Device, Medical, Health Care
  • Seed, Funding Round, Series B
  • Ireland
Portfolio highlights
  • FeelTect — FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous.
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
  • SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Atlantic Bridge VC Fund · Dublin, Dublin, Ireland · 10 investments in the past 12 months
Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.
Show more
Investment focus
  • Software, Artificial Intelligence, Analytics
  • Series A, Series B, Funding Round
  • United States, Ireland, United Kingdom
Portfolio highlights
  • Mitiga — Mitiga proactively stores and enhances forensic data so our experts can start incident investigations fast to get you back to business as usual
  • Insight Terra — Insight Terra supports data driven risk management in critical situations where business operations, people and the environment all come together.
  • Output Sports — Discover Output's portable and affordable athlete testing and tracking device. Measure strength, power and speed in minutes giving accurate and reliable data.
Furthr VC VC Fund · Dublin, Dublin, Ireland · 2 investments in the past 12 months
We are a relationship driven early stage VC investor. We invest in and form close partnerships with the founders we back.We make initial investments at Seed to Series A stage in highly ambitious, born global Irish software and medtech companies. We are hands-on and support teams across key strategic areas to accelerate growth.In addition toproviding institutional investment at an early stage, we reserve significant capital for following on in subsequent rounds. We go the journey with founders.
Show more
Investment focus
  • Medical Device, Medical, Software
  • Seed, Funding Round, Pre-Seed
  • Ireland
Portfolio highlights
  • Trustap — Learn how we make buying & selling online safe & secure, every time. Create an account for free today!
  • LaNua Medical — At LaNua Medical it is our mission to develop disruptive image-guided technologies providing safe and effective endovascular solutions.
  • STRATxAI — STRATxAI is a WealthTech Company based in Dublin, Ireland. Specialising in AI-driven model portfolios, combining decades of expertise with proprietary AI to serve Advisors and Institutional Investors. STRATxAI Model Portfolios are built to navigate market complexity and deliver attractive risk-adjusted returns. Through close collaboration withclients, we create bespoke portfolios tailored to their unique needs, preferences and risk profiles. Alana, our proprietary engine leverages advanced machine learning algorithms to streamline the implementation and management of adaptive. multi factor strategies.
Elkstone Capital Partners VC Fund · Dublin, Dublin, Ireland · 9 investments in the past 12 months
Elkstone is an investment firm, focusing on entrepreneurs, senior executives, institutional LPs, the venture community, and the Irish diaspora.The objective of the organization is to boost the economic value and overall well-being of the island of Ireland by expanding a network, facilitating deserving investments, and delivering excellentinvestment performance.
Show more
Investment focus
  • Software, Health Care, Artificial Intelligence
  • Seed, Funding Round, Series A
  • Ireland, United Kingdom, United States
Portfolio highlights
  • Advise — Advise Freemium is a ground-breaking automated data analytics for CPG solution. Discover how Advise can assist your Revenue Growth Management.
  • ZeroRisk.io — ZeroRisk.io is a platform for merchant management that provides cybersecurity and compliance solutions. It guarantees regulatory compliance, offers risk evaluation, and aids in risk mitigation. Additionally, it provides data analytics tools for performance optimization and growth opportunity identification. The platform offers real-time insightsand customization options.
  • Output Sports — Discover Output's portable and affordable athlete testing and tracking device. Measure strength, power and speed in minutes giving accurate and reliable data.
Enterprise Equity VC Fund · Dundalk, Louth, Ireland
Enterprise Equity (or EEVC) is an excellent for providing capital to early stage and expanding business throughout Ireland.
Show more
Investment focus
  • Software, Information Technology, Medical Device
  • Funding Round, Seed, Series B
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
  • SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
EIT Health VC Fund · Munich, Bayern, Germany
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more
Investment focus
  • Health Care, Medical Device, Medical
  • Grant, Pre-Seed, Seed
  • United Kingdom, Spain, Ireland
Portfolio highlights
  • IDOVEN — IDoven develops products to detect heart problems at an early stage to prevent heart diseases.
  • eBreathie — eBreathie is a pioneering digital health startup offering an integrated asthma management solution. Our system comprises a smart inhaler (a medical device) that not only tracks WHEN patients take their medication but also HOW they do it, creating a detailed inhalation profile for each use. Paired with a user-friendly mobile app for patients and acomprehensive patient management platform for doctors, we provide real-time feedback on inhalation efficacy, ensuring patients and healthcare professionals have the insights needed for optimal asthma management. Leveraging IoT and AI, our goal is to reduce emergency visits, asthma attacks, and hospitalizations while ensuring effective inhalation techniques and optimal patient care.
  • Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
Fountain Healthcare Partners VC Fund · Dublin, Dublin, Ireland · 2 investments in the past 12 months
Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Series C
  • Ireland, United States, France
Portfolio highlights
  • Mainstay Medical — Mainstay Medical is improving quality of life for patients with chronic low back pain through innovative restorative treatment medical device solutions.
  • Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
  • XyloCor Therapeutics — XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease. The company's service focuses on developing gene therapy to stimulate the formation of new coronary blood vessels and serve areas of the heart that are not receiving adequate blood supply, enabling patientswith refractory angina who exhausted pharmacologic options to cure their cardiovascular diseases painlessly and cost effectively.
EQT Life Sciences VC Fund · Amsterdam, Noord-Holland, The Netherlands · 13 investments in the past 12 months
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, The Netherlands, Switzerland
Portfolio highlights
  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
  • Avidicure — Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer
  • Atalanta Therapeutics — Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
Act Venture Capital VC Fund · Dublin, Dublin, Ireland · 3 investments in the past 12 months
Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth.We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internetand mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach.Act is based in Dublin, Ireland.Our most recent funds are supported by the European Investment Fund.
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Funding Round, Seed, Series A
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Trustap — Learn how we make buying & selling online safe & secure, every time. Create an account for free today!
  • Advise — Advise Freemium is a ground-breaking automated data analytics for CPG solution. Discover how Advise can assist your Revenue Growth Management.
  • Mavarick AI — Mavarick enables manufacturers to become more sustainable and productive.Our technology gives manufacturers precise and accurate information about their operations so they can reduce carbon emissions, increase productivity, and make better decisions across their business.Born on the shop floor and developed by data scientists, manufacturers,and sustainability experts, our easy-to-use tools make powerful AI solutions accessible to all the team.
Business Venture Partners VC Fund · Dublin, Dublin, Ireland · 2 investments in the past 12 months
Business Venture Partners was founded in 2004 as a corporate finance adviser for SME/owner managed businesses. The investment team is comprised of Elliott Griffin, Ronan Smith, Edel Coen and Mark Ruane and the team skills combine deep industry knowledge with experience in venture investing, corporate finance and international expansion. Theteam works on behalf of its clients buying and selling companies, raising finances, working with start-ups and advising on strategic growth, business succession and owner exits.Since 2007, BVP has successfully raised and managed 10 Simple Green BES and EII Funds. They have invested, on behalf of their investors, in some of Ireland’s most innovative companies such as Celtic Bioenergy, EFT Controls, and UrbanVolt. Our investment strategy is to spread investments over project finance and a portfolio of high potential companies. Their philosophy is to work hard with each investment to deliver valuable support for the company promoters and build shareholder value for their investors.In 2016 BVP launched The 10th BVP Green EII Fund. The fund provides eligible investors with the opportunity to avail of up to 40% income tax relief and provides the investor access to a portfolio of cleantech companies and renewable energy projects. The 11th Green Fund will be launched in Q4 2017.
Show more
Investment focus
  • Health Care, Information Technology, Medical
  • Seed, Funding Round, Series A
  • Ireland, Luxembourg, The Netherlands
Portfolio highlights
  • OOHPod — OOHPod, your new Out Of Home Flexible Address, will revolutionise the way you send and receive parcels
  • Advise — Advise Freemium is a ground-breaking automated data analytics for CPG solution. Discover how Advise can assist your Revenue Growth Management.
  • Positive Carbon — Positive Carbon provides an innovative solution for businesses to track, manage, and reduce food waste. With real-time analytics, CO2 calculation, and a comprehensive learning platform, we help you save costs and achieve sustainability goals. Request a demo today to start making a positive environmental impact.
AIB Seed Capital Fund VC Fund · Dublin, Dublin, Ireland
The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of €30m under managementwith AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.
Show more
Investment focus
  • Software, Health Care, Medical
  • Seed, Funding Round, Series A
  • Ireland, United States, Jersey
Portfolio highlights
  • NewsWhip — The only real-time media monitoring platform that predicts the stories and topics that will matter in the hours ahead.
  • Offr — Offr is the new way to buy and sell property, quickly and transparently.
  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Ascentifi VC Fund · Galway, Galway, Ireland
Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Funding Round, Series A
  • Ireland
Portfolio highlights
  • CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
  • Vertigenius — Vertigenius designs and deploys customized exercises using an easy-to-use clinician portal and even uses a Vertigenius head sensor to consult and manage patients with dizziness and imbalance.
  • X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.
Boole VC Fund
Boole
Show more
Investment focus
  • Medical Device, Health Care, Medical
  • Seed, Funding Round
  • Ireland
Portfolio highlights
  • Incereb — Incereb is an Irish medical device early stage company in the emerging neonatal intensive care unit (NICU) market. Founded in May 2011, Incereb is headquartered in Dublin, Ireland. The company designs and develops disposable Electroencephalography (EEG) and Cerebral Function Monitoring (CFM) products for term and preterm infants (neonates).These intuitive products are designed to be used with minimal training and will significantly reduce the time taken to set up the neonate for EEG and CFM monitoring. Their products are designed to interface with all brands of EEG and CFM recording equipment.Incereb is an award winning early stage company that plans to invest heavily in R&D, product design and development to evolve and extend its product range. Strategic alliances with leading Irish universities and hospitals enable Incereb to leverage home-grown scientific excellence to facilitate fast commercialisation of novel devices leading to rapid growth.
  • ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
Xenium Capital VC Fund
Xenium Capital
Show more
Investment focus
  • Medical Device, Health Care, Biotechnology
  • Seed
  • Ireland
Portfolio highlights
  • Atrian Medical — AtriAN is commercializing technology created at Mayo Clinic in the US. AtriAN is an Irish Medical Device company based in Galway--A powerful and prolific hub for medical devices.AtriAN uses a gentle energy, micro Pulsed Electric Fields (mPEF) to only ablate hyperactivity. The other tissues such as the myocardium are spared.
  • ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
  • Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland
Delta Partners VC Fund · Leopardstown, Dublin, Ireland · 4 investments in the past 12 months
Early stage VC investments and funding for start-ups / founders in Ireland.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Imvizar — Transform your buildings, office spaces, visitor attractions, and parks with an immersive and visual storytelling experience using augmented reality. Discover unique ways to tell your story at Imvizar.
  • ZeroMission — ZeroMission is an electromobility and lead innovator in software development, and power-energy infrastructure.ZeroMission offers fleet management software to businesses that own and operate fleets of commercial electric vehicles (EVs).
  • MarketSizer — MarketSizer offers subscription-based competitive intelligence and market insights for SaaS vendors who want to strategically grow their business.
NDRC VC Fund · Dublin, Dublin, Ireland · 2 investments in the past 12 months
NDRC builds high-impact new ventures. By providing the people, time, space and investment needed at the earliest stages of dedicated commercialisation work, NDRC is creating companies worthy of commercial investment and with the ability to scale. The NDRC team has the breadth of knowledge and expertise in technology and markets. NDRC worksside-by-side with researchers, entrepreneurs and venture teams to turn great ideas into successful new ventures.By the end of 2014, NDRC’s portfolio of startup ventures had secured a cumulative €88m in follow-on investment from commercial investors, with a combined market capitalisation of approx. €220m.
Show more
Investment focus
  • Software, Information Technology, E-Commerce
  • Seed, Pre-Seed, Convertible Note
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Nory AI — Revolutionise your restaurant with Nory's restaurant management software. Streamline operations, boost profits, and enhance decision-making in one platform.
  • Dataships — Dataships uses top level data privacy software to help your brand, no matter your location.
  • Ceartas DMCA — Ceartas is the leader in piracy protection for creators, brands & enterprise. Powered by AI, we have the highest removal rate in the industry
Medtech Syndicate Nominee VC Fund
Medtech Syndicate Nominee
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Seed, Series A, Funding Round
  • Ireland
Portfolio highlights
  • Kite Medical — Kite medical has developed a novel device for detecting Kidney Reflux in children with Urinary Tract Infections. The non-invasive diagnostic solution for kidney reflux removes the need for complicated procedures and a hospital visit. Kidney reflux is the most common urological disorder in childhood, affecting up to three per cent of young children.It is most prevalent from six months to five years of age. The condition may resolve as the child gets older, but left undiagnosed and untreated it can lead to permanent kidney damage and ultimately to kidney failure.
  • Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
Lightstone Ventures VC Fund · Menlo Park, California, United States · 6 investments in the past 12 months
Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, Ireland, Singapore
Portfolio highlights
  • FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
  • Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
  • Atsena Therapeutics — Atsena is a clinical-stage gene therapy company, focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness.
Seroba Life Sciences VC Fund · Dublin, Dublin, Ireland · 7 investments in the past 12 months
Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Funding Round
  • Ireland, United States, United Kingdom
Portfolio highlights
  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
  • Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
Boole Investment Syndicate VC Fund · Cork, Cork, Ireland
Boole Investment Syndicate invests in new technology start-up's with scalability.
Show more
Investment focus
  • Medical Device, SaaS, EdTech
  • Seed, Funding Round
  • Ireland, United States
Portfolio highlights
  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • FeelTect — FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous.
  • SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Broadview Ventures VC Fund · Boston, Massachusetts, United States · 6 investments in the past 12 months
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Seed, Series B
  • United States, Canada, Israel
Portfolio highlights
  • Aria CV — Learn about Aria CV's novel implantable medical device designed to treat pulmonary hypertension (PH). Our elegant device has no battery, pump, or electronics.
  • Alveron Pharma — Alveron produces drugs such as cyclodextrins, pro-coagualant cyclodextrins with a unique coagulation platform technology.
  • Relief Cardiovascular — Relief Cardiovascular is an inQB8 medical technologies portfolio company developing a revolutionary smart implant to decongest heart failure patients.
Kernel Capital VC Fund · Cork, Cork, Ireland
Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • Ireland, United Kingdom, France
Portfolio highlights
  • Cirdan — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
  • Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
  • Pilot Photonics — Welcome to Pilot Photonics, a laser product development company in Dublin, Ireland. We provide optical frequency combs and tunable lasers.
Gilde Healthcare VC Fund · Utrecht, Utrecht, The Netherlands · 10 investments in the past 12 months
Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series C, Series A
  • United States, The Netherlands, Germany
Portfolio highlights
  • FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
  • Noema Pharma — BEYOND SYMPTOM CONTROL Developing therapies to help both orphan and larger patient populations with conditions of the brain and nervous system live their li ...
  • Alleviant Medical — Interventional therapy for congestive heart failure
Oyster Capital Partners VC Fund · Blackrock, Dublin, Ireland
Oyster Capital Partners, an Irish private equity firm, specializes in the energy technology, IT, and healthcare sectors.
Show more
Investment focus
  • Software, Medical Device, Enterprise Software
  • Series A, Funding Round, Seed
  • Ireland, United Kingdom, United States
Portfolio highlights
  • Inclusio — The inclusio diversity and inclusion platform is designed to measure and positively shift the culture of your organisation. Contact us for more information.
  • Ooodles — Ooodles offers a complete IT procurement and management platform for companies looking to streamline hardware acquisition and scale effortlessly. Buy or Lease Laptops, Desktops, Monitors & Tablets for Office or Remote Workers. From laptops and monitors to tablets, our solution empowers businesses to procure, finance, manage, and optimize their IT needs in one place.
  • &Open — For businesses that gift to give back, share joy, or show they care. All you need is an email.
Mayo Clinic Ventures VC Fund · Rochester, Minnesota, United States
Mayo Clinic Ventures is dedicated to quickly bringing answers to the people who need them most: the patients living with diseases and conditions that threaten to limit or even end their lives. Our team works closely with Mayo physicians and scientists to mine inventions, ideas and discoveries that will truly transform health care. Their dedicatedefforts bring significant financial support to Mayo's patient care, education and research efforts.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • United States, Ireland, China
Portfolio highlights
  • JOGO Health — Wearbles and VR gaming to treat stroke, chronic pain and incontinence.
  • Turtle Health — Turtle Health is a virtual fertility counselling clinic. We provide you with personalized, medically meaningful information to help you plan your fertility journey, early and affordably.
  • The Patient Company — The Patient Company provides clinical staff members with an automated lateral patient transfer device called SimPull. The company was founded in 2019 by Andrew Heuerman and is based in Grand Rapids, Michigan.
imec.xpand VC Fund · Leuven, Vlaams-Brabant, Belgium · 4 investments in the past 12 months
Expanding nanotechnology into business.
Show more
Investment focus
  • Semiconductor, Medical Device, Manufacturing
  • Seed, Series A, Series B
  • Belgium, United States, The Netherlands
Portfolio highlights
  • Xavveo — Imaging RADAR enabled by Xavveo's Silicon Photonics Technology
  • Eyeo — eyeo revolutionizes imaging with color splitter sensors. Capture sharper, brighter images in low light using optical waveguide innovation, discover how it works
  • Vertical Compute — vertical compute is a european deep-tech semiconductor startup committed to advancing how data-intensive workloads, like generative ai, are processed
Life Sciences Fund Amsterdam VC Fund · Amsterdam, Noord-Holland, The Netherlands
Life Sciences Fund Amsterdam is an independent venture capital fund aiming to capitalize on new technological developments in the life sciences sector. It provides investment capital to fund high tech entrepreneurial activity in the Amsterdam Metropolitan Area in general and at the academic medical centres in particular. The fund is a specialistt fund, targeting companies that are developing commercially promising products and technologies in life sciences, including: pharmaceuticals, biotechnology, medical devices and other high technology opportunities that offer venture capital returns. The Fund focuses on seed and early stage companies, but also on pre-seed commercially viable academic projects.The close collaboration between the fund, the technology transfer offices of the Life Sciences Centre Amsterdam and the Amsterdam Biomed Cluster, enables the fund to facilitate the transfer of technology to the private sector and to provide emerging technology companies and university researchers with vital seed funding and specialized financial and technical assistance. The fund started in 2007 and is now fully invested.
Show more
Investment focus
  • Medical Device, Medical, Communities
  • Series A, Funding Round, Private Equity
  • Ireland, The Netherlands
Portfolio highlights
  • Sigmascreening — Pucuk138 merupakan situs andalan Slot88 official gampang gacor dengan bet 100,200 dan 500 perak Auto Maxwin dengan winrate tertinggi.
  • Neurent Medical — Neurent Medical is dedicated to developing highly innovative non-surgical interventions that treat chronic inflammatory Sino-Nasal diseases.
Cantor Fitzgerald VC Fund · New York, New York, United States · 2 investments in the past 12 months
Cantor Fitzgerald is a global financial services firm that specializes in equities, investment banking, and real estate, fixed income and currencies, prime services, and, affiliates. The firm is known for developing advanced technologies to expand market access, and help clients achieve their most important financial and strategic objectives. Thiscommitment to client-centered innovation has led to enduring relationships with many of the world’s most demanding institutional investors and corporations. The company was founded in 1945 and is headquartered in New York.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Post-IPO Equity, Series B, Series A
  • United States, Canada, Ireland
Portfolio highlights
  • Neeve — Neeve is a unified platform to cybersecure your building, deploy smart building applications, unlock building data, and accelerate your journey to the cloud.
  • View — View is the leader in smart building technologies that transform buildings to improve human health and experience, reduce energy consumption and carbon emissions, and generate additional revenue for building owners. View Smart Windows use artificial intelligence to automatically adjust in response to the sun, increasing access to natural light andunobstructed views while eliminating the need for blinds and minimizing heat and glare. Every View installation includes a cloud-connected smart building platform that can be extended to reimagine the occupant experience. View is installed and designed into over 90 million square feet of buildings, including offices, hospitals, airports, educational facilities, hotels, and multifamily residences. For more information, please visit: www.view.com.
  • Strive Asset Management — Strive is an asset management firm whose mission is to restore the voices of everyday citizens in the American economy by leading companies to focus on excellence over politics.
Faber VC Fund · Lisbon, Lisboa, Portugal · 7 investments in the past 12 months
Faber is a Lisbon-based venture capital firm investing in outstanding entrepreneurs who innovate at the intersection of science and technology to drive digital transformation and climate action. The firm combines a specialist focus on deep tech early-stage startups with dedicated funds, investment teams and expert advisors to actively help foundersbuild global companies powered by AI/data or climate/ocean technologies. Faber’s unique approach in Southern Europe is led by an entrepreneurial management partnership and backed by notable thesis-driven institutions and private investors. Investing since 2013, the firm has been an early investor in hard tech companies such as Unbabel, SWORD Health, Codacy, iLoF or YData
Show more
Investment focus
  • Software, Machine Learning, SaaS
  • Seed, Pre-Seed, Series A
  • Portugal, United Kingdom, United States
Portfolio highlights
  • Meight — Run your cargo on budget and on time with a few simple clicks, from your laptop. Forget phone calls, driver headaches, hardware and tech nightmares, forever.
  • PHOTON IP — PHOTON IP is a deeptech startup based in Eindhoven, the Netherlands. The company develops cutting edge technologies for advanced photonics applications.
  • KOA Biotech — Detecta enfermedades a tiempo y maximiza tus resultados.
CAJU Venture Partners VC Fund · Amsterdam, Noord-Holland, The Netherlands
Caju Venture Partners invests in MedTech in the European Union. Caju Venture Partners invests in entrepreneurs with high integrity who can establish great businesses and impact healthcare in the future.
Show more
Investment focus
  • Health Care, Medical Device
  • Funding Round
  • Ireland
Portfolio highlights
  • FeelTect — FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous.
European Investment Bank VC Fund · Luxembourg, Luxembourg, Luxembourg · 35 investments in the past 12 months
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more
Investment focus
  • Biotechnology, Health Care, Energy
  • Debt Financing, Post-IPO Debt, Funding Round
  • France, Germany, The Netherlands
Portfolio highlights
  • UP Catalyst — UP Catalyst produces sustainable carbon nanomaterials and graphite for the green energy storage industry.
  • Sidekick Health — Our mission is to develop and deliver effective personalized digital therapeutics that prevent suffering and add millions of quality life years to people around the world. Our multi-chronic digital care platform allows us to scale the production of clinical treatments across major chronic diseases.
  • Heura Foods — Heura is a plant based startup founded by food activists Marc Coloma and Bernat Añaños in April 2017. Its mission is to create solutions that will leave the current food system obsolete and accelerate the transition to a world where animals are out of the equation. Their Mediterranean culinary heritage is reflected on their products: clean label,high nutritional values and taste.
Partisan Management Group VC Fund · Evergreen, Colorado, United States
Partisan Management Group is a highly successful, early stage venture capital investor in medical device companies.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Funding Round, Series A, Series B
  • United States, Ireland
Portfolio highlights
  • TriSalus Life Sciences — Surefire Medical, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The Surefire's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, whichcollapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.
  • Enable Injections — Enable Injections designs, manufactures, and sells wearable delivery devices for injectable drugs. The Enable Injections products can deliver drugs directly from standard vials supplied by all pharmaceutical companies, can reconstitute powdered drugs into liquids as a part of the injection procedure, can inject very viscous drugs, and can inject upto 20 ml. Such products are called bolus injection systems. No other existing drug delivery device can accomplish all of these tasks. Approximately 900 new drugs are being developed that may require bolus injection technology like that being developed by Enable Injections. The total market is expected to reach $8 billion within ten years. Partisan principals have supplied 10% of the seed capital to Enable Injections. It also delivers a controlled flow of up to 50 ml of a biologic through an automatically inserted needle. Enable Injections also offers a version of the drug delivery platform that may connect to smartphones via Bluetooth. It also utilizes any standard container closure system, including syringes or vials; automatically warms and can automatically mix lyophilized solutions.Enable Injections was founded in 2010 and is headquartered in Cincinnati, Ohio, USA.
  • Ponce De Leon Pharmaceuticals — Ponce De Leon Pharmaceuticals is a privately financed development stage company, committed to the extension of human health span, endeavoring to offer more healthy years of living. In conjunction with the Buck Institute for Research on Aging, the Company has developed a formulation comprised of GRAS (Generally Regarded As Safe) components. Thisformulation has been shown to radically increase mean lifespan in the invertebrate model (C. Elegan), well beyond any previously published data on drugs or compounds. Testing has now begun at the Buck Institute in the mammalian model (mouse), and the Company hopes to have a patent pending product available to the public at the conclusion of those studies, or in about three years.
Glanzmann Enterprises VC Fund
Glanzmann Enterprises
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A, Funding Round
  • Ireland
Portfolio highlights
  • Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
Pareto Holdings VC Fund · Miami, Florida, United States · 20 investments in the past 12 months
Building world-changing companies in sunny Miami
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Pre-Seed, Funding Round
  • United States, United Kingdom, France
Portfolio highlights
  • Revv — Revolutionize your calibration processes with Revv ADAS: lightning-fast calibration identification, comprehensive OEM data, and seamless insurance-ready invoicing, all in one powerful solution for increased efficiency, accuracy, and profitability.
  • Omada — Get in on the action with Omada, the ultimate and insanely fun Sports Prediction Community.
  • Devolut — Devolut offers a product designed for businesses and enhancing customer experience. The Company uses intelligent algorithms to boost sales, reduce costs, and improve customer experience through reusable shipments and a real-time management portal.
The University of Vermont Health Network VC Fund · Burlington, Vermont, United States
Welcome to The University of Vermont Health Network, five partner hospitals serving the residents of Vermont and northern New York. With over 4,000 health care providers throughout our region, they work together to offer high-quality care more cost-efficiently and as close to home as possible. Strengthened by their connection, each of theirhospitals remains committed to its local community and to the heart and science of medicine: compassionate, personal care shaped by the latest medical advances and delivered by highly skilled experts.
Show more
Investment focus
  • Medical, Biotechnology, Fashion
  • Seed, Series B, Funding Round
  • United States, Ireland
Portfolio highlights
  • BioFactura — BioFactura has developed the StableFast™ Biomanufacturing Platform, a novel system to rapidly generate stable NS0 cell lines for biopharmaceutical manufacturing. The elements of this system include a chemically-defined, serum- and cholesterol-free production medium and pre-adapted parental cells, modular expression vectors that utilize a patentedselection strategy, and a proprietary growth supplement that permits rapid generation and cloning of cell lines. This platform is simple to use, fast, and productive. A clonal production cell line can be developed and scaled up to yield over one gram of product in less than eight weeks.
  • THEYA Healthcare — Creators of the Post Surgery Bra proven to heal. Hypoallergenic and Antibacterial Underwear for Sensitive Skin, Post Partum, and Menopause using soft, safe & sustainable bamboo. Post-Op wear from labiaplasty recovery to stoma briefs. Mastectomy and breast cancer care specialists. Sizes XS to 4XL & Worldwide Shipping!
  • Veralox Therapeutics — Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
HBM-MedFocus VC Fund
HBM-MedFocus
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B
  • Ireland, United States
Portfolio highlights
  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
  • Viseon — Viseon is a privately held medical device company committed to developing proprietary technology for use in Minimally Invasive Spine Surgery (MISS) procedures. Viseon has progressed rapidly over the past 6-months, having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive spine surgeryprocedures. In addition to rapid product development of its initial products, Viseon has assembled a world-class Scientific Advisory Board of leading MISS physicians, amassed 13 patents to solidify its intellectual property platform, and completed a series of pre-clinical studies supporting initial human-use, scheduled to begin soon.Viseon was founded in early 2017 as a spin-out from Rebound Therapeutics Corporation.
Quorndon Capital VC Fund
Quorndon Capital is a Investment Firm.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A
  • Ireland
Portfolio highlights
  • HealthBeacon — Quality adherence support for your medication needs, contact our HealthBeacon team to discover what service we can provide you and your patients.
Lachy Groom VC Fund · West Hollywood, California, United States
Lachy Groom
Show more
Investment focus
  • Software, Financial Services, Artificial Intelligence
  • Series A, Seed, Series B
  • United States, Brazil, Israel
Portfolio highlights
  • Riverside.fm — Riverside.fm makes it easy for podcasters and media companies to record remote interviews in studio quality. End result? 4k video and WAV audio content.
  • Standard Bots — The new standard for robotics.
  • Luminate Medical — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
Norgine Ventures VC Fund · Uxbridge, Hillingdon, United Kingdom
Norgine Ventures was started in 2012 to diversify Norgine’s activities and foster innovation in the healthcare sector. Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US. Norgine Ventures is backed by Norgine, a fully integrated, private,European healthcare company with over 110 years of experience in the pharma space.Norgine Ventures has full access to Norgine’s technical capabilities for evaluating investment opportunities, although the business is aimed at achieving a financial return rather than funding opportunities of strategic interest to Norgine.To date, Norgine Ventures has invested in a number of businesses, including specialty pharma, diagnostic and medical device companies, at various stages of their life cycle, both in Europe and in the US.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Funding Round, Debt Financing, Series A
  • France, United Kingdom, United States
Portfolio highlights
  • ImaginAb — ImaginAb is a biotechnology company focused on developing a new class of highly targeted diagnostic imaging agents based on engineered antibody fragments. ImaginAb's platform technology enables the rapid engineering of antibodies into fragments that retain the parental antibody but are immunologically passive and kinetically-optimized forclinical imaging. This combination of superior specificity and kinetics enables ImaginAb to generate agents that can address the unmet needs in diagnosis and patient selection for therapeutics.
  • PathoQuest — PathoQuest provides biosafety assays based on next-generation sequencing (NGS) for biologics quality testing. GMP biotesting for biopharmaceuticals. Learn more.
  • Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.
COSIMO Ventures VC Fund · Dublin, Dublin, Ireland
COSIMO digital, previously COSIMO Ventures, is a pioneering digital asset management firm offering asset management, advisory, custody, broker-dealer, and blockchain and Web3 development services.
Show more
Investment focus
  • Enterprise Software, Blockchain, Sports
  • Seed, Series A, Funding Round
  • Japan, Ireland, United States
Portfolio highlights
  • Defactor — Globally empowering businesses to tokenise real-world assets by offering decentralised open-source financial technology. Unlock a new financial future.
  • ICHI — Grow any token with low-slippage, on-chain liquidity
  • BEASY — BEASY Wallet & Forge makes it easy for collectors and creators to mint, buy, sell, trade, and manage their own NFTs. No crypto knowledge required!
GM&C Life Sciences Fund VC Fund · Alderley Edge, Cheshire, United Kingdom
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Seed, Funding Round, Series A
  • United Kingdom, Italy, Germany
Portfolio highlights
  • ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
  • Flynotes — Flynotes is a digital software platform helping dentists deliver personalised patient care
  • QV Bioelectronics — Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.
Bioverge VC Fund · San Francisco, California, United States
Bioverge is a venture capital firm specializing in emerging healthcare startups. The firm operates Bioverge.com, an investment platform that aims to democratize access to startups solving healthcare’s biggest challenges and accelerate their progress.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Seed, Series A, Series B
  • United States, Ireland, United Kingdom
Portfolio highlights
  • UBERDOC — Established in 2016, UBERDOC provides priority access to the best doctors for an affordable, transparent price. The company offers free directory listing to qualified Medical Doctors and free membership to patients. Its unrivaled mobile technology and transparent pricing structure make it simple and easy for patients needing urgent medical care toinstantly connect to a choice of specialists without requiring a referral, insurance paperwork or having to wait many months for an appointment. The Boston-based, privately held company was founded by Paula Muto, MD, FACS, a Vascular and General Surgeon. Muto has been credited as an expert in the healthcare industry by publications like Huffington Post, Fox business, Becker’s Hospital Review, General Surgery News, and Boston magazine.UBERDOC, Inc., a digital platform for direct-pay healthcare, has grown from a Boston-based startup to a nationally recognized member of the digital health community, having participated in several conferences in Boston, New York, Chicago and San Francisco. Thousands of doctors across the US are enrolled on the UBERDOC platform with patients using its service daily.At www.uber-docs.com (https://uber-docs.com/), patients search by medical specialty, book and pay for a doctor appointment using an HSA (Health Savings Account), FSA or credit card, and see the Medical Doctor at the scheduled time and place. A $50 transaction fee secures the appointment, and $250 is charged after the consult is determined completed by the doctor. Doctors are paid immediately and directly through the UBERDOC platform.
  • Jelikalite — JelikaLite is developing an innovative solution to permanently reduce a child's autism symptoms. Discover Precision Autism Through Light!
  • My Diabetes Tutor — My Diabetes Tutor was recently named the first accredited diabetes education telehealth program in California by the American Association of Diabetes Educators (AADE), a National Accredited Organization (NAO). This will provide individuals with diabetes increased access to high quality diabetes education services. My Diabetes Tutor was named thefirst accredited diabetes education telehealth program in California by the Association of Diabetes Care and Education Specialists (ADCES), (etc). My Diabetes Tutor recently did a scientific presentation at the American Diabetes Association Scientific Meeting 2022 and our abstract is published in the Diabetes Journal.
Sure Valley Ventures VC Fund · London, England, United Kingdom
An entrepreneur led Venture Capital Fund that invests in early stage software companies. Working in partnership with Shard Capital, a specialist broker and asset manager based in the City of London, Sure Valley Ventures specialises in investing in Augmented Reality (AR) and Virtual Reality (VR), Financial Technology (FinTech), and the Internet ofThings (IoT) Sectors.
Show more
Investment focus
  • Software, Virtual Reality, Augmented Reality
  • Seed, Series A, Funding Round
  • Ireland, United Kingdom
Portfolio highlights
  • Captur — Captur helps companies make smarter decisions, at the speed of capturing a photo. We use expert triaging and visual AI to identify and action tasks instantly for companies managing in-field operations.
  • Jaid — Jaid is an AI-powered platform that extracts critical data from diverse company and customer communications.
  • Everyangle — Everyangle facilitates business in computer vision applications based on cisco meraki MV smart cameras across retail and industrial firms.
Kidron VC Fund · Tel Aviv, Tel Aviv, Israel
Kidron Capital Assets LP is the Women's Health Venture Capital Fund. Kidron’s investments will include a mix of medical devices, diagnostics, services, therapeutics, and digital health.
Show more
Investment focus
  • Health Care, Medical Device
  • Series B
  • France
Portfolio highlights
  • May Health — May Health is developing a modern treatment - Ovarian Rebalancing - designed to restore ovulation for people with polycystic ovary syndrome.
  • NUA Surgical — NUA Surgical is an award-winning Irish MedTech company developing innovative solutions in obstetrics and gynaecology.
Investors by industry
Investors by country
VC (Venture Capital) Funds in Ireland by industry